Today: 29 June 2026
Browse Category

Stock Market 20 January 2026

Rio Tinto share price slips in London as iron ore weakens and Glencore clock ticks

Rio Tinto share price slips in London as iron ore weakens and Glencore clock ticks

Rio Tinto shares fell 0.8% to 6,287 pence in early London trading as iron ore futures hit a two-week low, with China’s May contract down 2.82% to 792 yuan a ton. BHP confirmed it is offering price concessions in 2026 supply talks with China’s state buyer. Investors are watching Rio’s quarterly update and a Feb. 5 deadline for Glencore’s potential offer.
20 January 2026
····
Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

Unilever shares slipped 0.7% to 4,732.5p in early London trading Tuesday, tracking broader declines in European markets after renewed U.S. tariff threats. Berenberg reiterated its Buy rating and 5,600p target. Investors await Unilever’s Feb. 12 results, the first since the ice cream division demerger, for updates on volumes and margins. Year to date, the stock is down about 2.6%.
20 January 2026
·
Glencore share price slips in London as BlackRock filing keeps Rio Tinto deal watch alive

Glencore share price slips in London as BlackRock filing keeps Rio Tinto deal watch alive

Glencore shares slipped 0.4% to 478.95 pence after Rio Tinto confirmed talks on an all-share takeover, triggering speculation and regulatory scrutiny. BlackRock disclosed a 7.17% stake and a 0.07% short position. China’s antitrust review could require asset sales if a deal proceeds. Investors await Glencore’s production report on Jan. 29 and 2025 results on Feb. 18.
20 January 2026
····
Why London Stock Exchange Group (LSEG) share price is sliding: buyback filing lands as UK reforms and tariff jitters collide

Why London Stock Exchange Group (LSEG) share price is sliding: buyback filing lands as UK reforms and tariff jitters collide

London Stock Exchange Group shares fell 1.2% to 8,974 pence by 0826 GMT after announcing new buybacks and the purchase of 110,386 shares for cancellation. Britain’s new capital-raising rules took effect, raising the prospectus threshold and aiming to cut costs. London markets dropped after President Trump announced a 10% tariff on UK and European imports, effective Feb. 1. LSEG will report preliminary 2025 results on Feb. 26.
20 January 2026
···
Compass Group share price slips in early London trade as tariff jitters hit markets; Feb 5 update looms

Compass Group share price slips in early London trade as tariff jitters hit markets; Feb 5 update looms

Compass Group shares fell 0.8% to 2,264.5 pence in early London trading Tuesday, extending a five-day slide to 2.2%. The drop tracked broader market weakness amid renewed tariff threats and global risk aversion. No new company news moved the stock. Investors are eyeing Compass’s Feb. 5 trading update and annual meeting, with a final dividend set for Feb. 26.
20 January 2026
··
Lloyds share price near 102p: what could move LLOY.L at the London open

Lloyds share price near 102p: what could move LLOY.L at the London open

Lloyds Banking Group closed Monday at 102.30 pence, near recent highs, after filing a share plan ahead of full-year results due January 29. The FTSE 100 fell 0.4% as Trump’s tariff threats hit sentiment. UK payrolls dropped by 43,000 in December, fueling bets on a 2026 Bank of England rate cut. Lloyds still faces uncertainty over an £800 million charge from the motor finance mis-selling scandal.
20 January 2026
·
IEX share price slides as India holds firm on market coupling ahead of APTEL hearing

IEX share price slides as India holds firm on market coupling ahead of APTEL hearing

IEX shares fell 1.47% to 137.1 rupees Monday after the power minister said there was no change in market coupling policy. The Electricity Appellate Tribunal is set to review IEX’s challenge to a July 2025 order mandating day-ahead market coupling. Regulators warn the move could centralize power price-setting and disrupt competition. IEX alleges regulatory flaws and insider trading in its legal filings.
20 January 2026
··
1 … 666 667 668 669 670 … 1,601

Stock Market Today

  • Neurocrine Biosciences (NBIX) Gains as Strong Earnings Forecasts Boost Stock
    June 29, 2026, 5:49 AM EDT. Neurocrine Biosciences (NBIX) has emerged as a robust biotech performer with strong earnings momentum driven by its flagship treatment INGREZZA, which treats movement disorders. Analysts have sharply raised earnings per share (EPS) estimates for NBIX across upcoming quarters and fiscal years, reflecting increased confidence in the stock. INGREZZA's sales reached $2.86 billion in 2025, up 22% year-over-year, with projected growth continuing in 2026. The company also benefits from growing physician adoption and expanding patient awareness. Rising earnings forecasts, driven by strong operational performance and a broad consensus among analysts, have elevated NBIX to a Zacks Rank #1 (Strong Buy). Investors see Neurocrine's expanding portfolio and pipeline as key to sustaining growth beyond INGREZZA's success.

Latest articles

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

29 June 2026
ServiceNow (NYSE:NOW) surged 9.85% to $98.34 Friday, adding $9.1 billion in equity value—about 72% of its $12.64 billion Q1 current remaining performance obligations—as software stocks outperformed amid rotation out of AI names; the move comes ahead of a potential near-term bookings catalyst tied to price increases and legacy tier retirements, with short interest at 5.82% of float.
Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

29 June 2026
Nvidia’s $4.7 trillion market value means every 1% stock move shifts $47 billion, putting massive index risk in focus as AI capex spending faces fresh scrutiny from new BIS data and rising China chip competition, with premarket gains tested by funding and substitution risks.
Go toTop